<DOC>
	<DOCNO>NCT00853255</DOCNO>
	<brief_summary>Over past decade , avian influenza ( AI ) become major health concern . The development safe effective vaccine avian strain infect people important . The purpose study determine safety immune response investigational AI vaccine healthy adult H7N3 strain avian influenza .</brief_summary>
	<brief_title>Group Study Safety Immune Response Single Dose Bird Flu Vaccine ( H7N3 ) Healthy Adults</brief_title>
	<detailed_description>The current pandemic risk associate avian influenza H7N3 infection significant , increase number human infect . H7 influenza transmission usually occur human expose direct contact infect poultry surface object contaminate infected poultry feces . A pandemic occur new influenza subtype emerge infects human , cause serious illness , spread easily human . The development safe effective vaccine necessary . The purpose study evaluate safety immunogenicity one-dose administration live , attenuate AI virus vaccine , H7N3 ( 6-2 ) AA ca Recombinant ( A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca ) . This study last approximately 180 day . Participation study include one 12-day hospital stay isolation unit University Rochester Vaccine Evaluation Isolation Unit St. Mary 's Hospital Rochester , NY . All participant receive one dose vaccine nasal spray form study entry . Participants admitted isolation unit 2 day prior vaccination . A targeted physical exam , vital sign measurement , nasal wash occur daily follow vaccination discharge . Participants discharge two consecutive nasal wash Day 7 negative . Blood urine collection occur select timepoints throughout study . Follow-up outpatient visit occur approximately Days 28 , 56 , 180 . A nasal wash adverse event evaluation occur follow-up visit .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Good general health Available duration trial For female , willing use acceptable form contraception duration study . More information criterion find protocol . Clinically significant neurologic , heart , lung , liver , rheumatologic , autoimmune , kidney disease Behavioral cognitive impairment psychiatric disease , opinion investigator , may affect study participation Previously enrol H7N3 influenza vaccine trial study avian influenza vaccine Seropositive H7N3 influenza A virus ( serum hemagglutination inhibition [ HI ] titer great 1:8 ) Illegal drug use dependency determine urine test Medical , work , family problem result alcohol illicit drug use within 12 month prior study entry History severe allergic reaction Allergy oseltamivir Asthma reactive airway disease within 2 year prior study entry History GuillainBarre syndrome HIVinfected Hepatitis C virus infect Positive hepatitis B surface antigen ( HBsAg ) Known immunodeficiency syndrome Use corticosteroid immunosuppressive drug within 30 day prior vaccination . Participants use topical corticosteroid exclude . Receipt live vaccine within 4 week prior study vaccination Receipt kill vaccine within 2 week prior study vaccination Absence spleen Receipt blood product within 6 month prior study vaccination Current smoker unwilling stop smoking duration study Have travel Southern Hemisphere within 14 day prior study vaccination Have travel cruise ship within 14 day prior study vaccination Work poultry industry within 14 day prior study vaccination Other investigational vaccine drug within 30 day prior study vaccination Allergy egg egg product Other condition , opinion investigator , may interfere study Pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Bird Flu</keyword>
</DOC>